Echosens company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

echosens.us

About Echosens

Echosens, founded in 2001, manufactures FibroScan, a non-invasive solution that accurately measures liver stiffness and liver steatosis for comprehensive management of liver disease. It is based in Paris, France.

Echosens Headquarter Location

Paris, 75014,

France

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Echosens News

VIDEO: AACE tailors new fatty liver guideline to endocrinologists

May 13, 2022

Published by: Disclosures: Cusi reports receiving research support as principal investigator for the University of Florida from Cirius Therapeutics, Echosens, Inventiva, Novartis International, Novo Nordisk, Poxel and Zydus Pharmaceuticals, and serving as a consultant for Allergan, Altimmune, Arrowhead Pharmaceuticals, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Coherus BioSciences, Eli Lilly and Co., Fractyl Health, Hanmi Healthcare, Genentech, Gilead Sciences, Intercept Pharmaceuticals, Janssen Pharmaceuticals, Pfizer, Prosciento, Madrigal Pharmaceuticals and Novo Nordisk. Leffert reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio SAN DIEGO — In this video exclusive, Jonathan D. Leffert, MD, talks with Kenneth Cusi, MD, FACP, FACE, about the new American Association of Clinical Endocrinology nonalcoholic fatty liver disease guideline tailored for endocrinologists. Leffert is managing partner at North Texas Endocrine Center and past president of AACE. Cusi is chief of the division of endocrinology, diabetes and metabolism at the University of Florida in Gainsville. Both are Endocrine Today Editorial Board Members. They discuss the great prevalence of NAFLD among people with type 2 diabetes, how to diagnose NAFLD and medications on the horizon for treatment. Read more about

  • Where is Echosens's headquarters?

    Echosens's headquarters is located at Paris.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.